Level Bio AB (publ) (NGM:LEVBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2640
+0.0100 (3.94%)
At close: Sep 3, 2026

Level Bio AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
34.3732.3625.126.134.3343.96
Revenue Growth
14.34%28.95%-3.83%-23.99%-21.91%86.86%
Gross Profit
17.8717.0613.4912.3115.2517.88
Operating Income
-1.43-3.49-8.08-9.73-2.335.26
Net Income
4.76-3.54-7.87-9.48-2.225.16
Earnings Per Share
--0.05-0.12-0.15-0.040.08
EPS Growth
-----179.27%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.082.481.083.637.845.86
Total Debt
-21.411.110.60.9
Net Cash (Debt)
0.080.49-0.332.527.244.96
Net Cash Growth
-94.99%---65.16%45.93%2154.38%
Net Cash Per Share
-0.01-0.000.040.110.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.380.82-4.46-5.452.871.63
Capital Expenditures
----0.04-0.07-
Free Cash Flow
-0.380.82-4.46-5.492.791.63
Free Cash Flow Growth
----71.85%-11.61%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
51.98%52.70%53.77%47.16%44.43%40.67%
Operating Margin
-4.17%-10.78%-32.21%-37.30%-6.79%11.96%
Pretax Margin
14.21%-11.02%-32.65%-37.15%-7.03%11.86%
Profit Margin
13.84%-10.94%-31.37%-36.31%-6.48%11.73%
FCF Margin
-1.11%2.54%-17.78%-21.03%8.14%3.70%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.80----31.60
P/FCF Ratio
-25.01--16.92100.19
PS Ratio
0.530.630.750.991.383.71